department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

EXEMESTANE · pharmadog

pharmadog
drugs
EXEMESTANE

drug

patient view →

EXEMESTANE

Marketedupdated 2mo ago

by $PFE PFIZER INC

Approved

community read0 votes

indications

investigational

Breast Cancer

all catalysts(8)

approval · 8

view all 8 catalysts →

News(0)

no news has mentioned this drug yet

brand

EXEMESTANE

generic

EXEMESTANE

indication

Metastatic Breast Cancer

phase

marketed

EXEMESTANE — FDA approval

EXEMESTANE — FDA approval

EXEMESTANE — FDA approval

EXEMESTANE — FDA approval

EXEMESTANE — FDA approval

EXEMESTANE — FDA approval

EXEMESTANE — FDA approval

EXEMESTANE — FDA approval

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov

last refreshed 50m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 2

tagApproval16 co-mentions · 8 sources
tagSmall Molecule8 co-mentions · 8 sources

Trials studying EXEMESTANE

phase2First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumorsrecruitingn=880
phase3Phase IIIb Study of Ribociclib + ET in Early Breast Cancerrecruitingn=1,400
phase2Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)recruitingn=120
phase3Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)recruitingn=220
phase3A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)recruitingn=920
phase2A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancerterminatedn=6
phase3A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrencerecruitingn=4,220
phase1A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumorsactive not recruitingn=193

more trials →